51 related articles for article (PubMed ID: 23086971)
1. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
Nerla R; Di Franco A; Milo M; Pitocco D; Zaccardi F; Tarzia P; Sarullo FM; Villano A; Russo G; Stazi A; Ghirlanda G; Lanza GA; Crea F
Heart; 2012 Dec; 98(24):1812-6. PubMed ID: 23086971
[TBL] [Abstract][Full Text] [Related]
2. Effects of ivabradine and atenolol on heart rate and heart rate variability in healthy cats over a 24 h period: A pilot study.
Ogawa M; Kawamura A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
Vet Rec Open; 2022 Dec; 9(1):e28. PubMed ID: 35154785
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycocalyx-targeted therapy on vascular function in older adults: a randomized controlled trial.
Gimblet CJ; Ernst JW; Bell B; Bos KD; Stroud AK; Wendt LH; Donato AJ; Jalal DI; Pierce GL
J Appl Physiol (1985); 2024 Jun; 136(6):1488-1495. PubMed ID: 38722754
[TBL] [Abstract][Full Text] [Related]
4. Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats.
Kawada T; Shimizu S; Uemura K; Hayama Y; Yamamoto H; Shishido T; Nishikawa T; Sugimachi M
J Physiol Sci; 2019 Mar; 69(2):211-222. PubMed ID: 30191411
[TBL] [Abstract][Full Text] [Related]
5. Personalised perioperative dosing of ivabradine in noncardiac surgery: a single-centre, randomised, placebo-controlled, double-blind feasibility pilot trial.
White MJ; Zaccaria I; Ennahdi-Elidrissi F; Putzu A; Dimassi S; Luise S; Diaper J; Mulin S; Baudat AD; Gil-Wey B; Elia N; Walder B; Bollen Pinto B
Br J Anaesth; 2024 Jul; ():. PubMed ID: 38960832
[TBL] [Abstract][Full Text] [Related]
6. A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation.
Katheria A; Kapoor A; Sahu A; Raut K; Khare H; Khanna R; Kumar S; Garg N; Tewari S
Indian Heart J; 2023; 75(5):376-382. PubMed ID: 37666416
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril].
Musikhina NA; Gapon LI; Utesheva AB; Petelina TI; Kolesnikova SN
Ter Arkh; 2012; 84(12):30-4. PubMed ID: 23479985
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Riccioni G; Prencipe G; Benvenuto A; Masciocco L; Ventra S; Rizzo U; Russi C; Speziale G
Pharmacology; 2013; 91(1-2):35-8. PubMed ID: 23146926
[TBL] [Abstract][Full Text] [Related]
9. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine and patients with coronary artery disease: more cardiovascular events.
Prescrire Int; 2014 Dec; 23(155):295. PubMed ID: 25629146
[No Abstract] [Full Text] [Related]
11. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.
Serhiyenko VA; Serhiyenko AA
World J Diabetes; 2018 Jan; 9(1):1-24. PubMed ID: 29359025
[TBL] [Abstract][Full Text] [Related]
12. The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial.
Tripolt NJ; Aberer F; Riedl R; Hutz B; Url J; Dimsity G; Meinitzer A; Stojakovic T; Hödl R; Brodmann M; Hafner F; Sourij H
Trials; 2016 Oct; 17(1):495. PubMed ID: 27733180
[TBL] [Abstract][Full Text] [Related]
13. Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
Mangiacapra F; Colaiori I; Ricottini E; Balducci F; Creta A; Demartini C; Minotti G; Di Sciascio G
Clin Res Cardiol; 2017 Jan; 106(1):69-75. PubMed ID: 27520989
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients.
Tanboğa İH; Topçu S; Aksakal E; Gulcu O; Aksakal E; Aksu U; Oduncu V; Ulusoy FR; Sevimli S; Kaymaz C
Clin Cardiol; 2016 Oct; 39(10):615-620. PubMed ID: 27511965
[TBL] [Abstract][Full Text] [Related]
15. New Insight into Effects of β-Blockers on Arterial Functions.
Eguchi K
Pulse (Basel); 2016 Apr; 3(3-4):190-4. PubMed ID: 27195240
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial dysfunction and pharmacological treatment.
Su JB
World J Cardiol; 2015 Nov; 7(11):719-41. PubMed ID: 26635921
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
Barzilai M; Jacob G
Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241226
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Martin RI; Pogoryelova O; Koref MS; Bourke JP; Teare MD; Keavney BD
Heart; 2014 Oct; 100(19):1506-10. PubMed ID: 24951486
[TBL] [Abstract][Full Text] [Related]
19. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
